TY - JOUR
KW - Treatment
KW - Rifampicin
KW - Paucibacillary leprosy
KW - leprosy
KW - Dapsone
KW - China
AU - Wen-Zhong L
AU - Gan-Yun Y
AB - The effects of six months of treatment with rifampicin (RFP) and dapsone (DDS) recommended by WHO in 61 untreated paucibacillary leprosy patients are reported through 2 years follow-up. At the end of six months of treatment, 53 cases (86.9%) remained active with an inactivity index of 0.13, and at the time of 12 months of follow-up, 21 cases (34.3%) were active,with an inactivity index of 0.66. 

BT - Chinese Journal of Dermatology
IS - 6
LA - chi
N2 - The effects of six months of treatment with rifampicin (RFP) and dapsone (DDS) recommended by WHO in 61 untreated paucibacillary leprosy patients are reported through 2 years follow-up. At the end of six months of treatment, 53 cases (86.9%) remained active with an inactivity index of 0.13, and at the time of 12 months of follow-up, 21 cases (34.3%) were active,with an inactivity index of 0.66. 

PY - 1988
SP - 355
EP - 357
T2 - Chinese Journal of Dermatology
TI - [Results of six-month treatment of paucibacillary leprosy patients with rifampicin and dapsone]
VL - 21
ER -